Intest Res Search

CLOSE


Editorial

  • HOME
  • ARTICLE CATEGORY
  • Editorial
Are the risks of colorectal cancer and biliary cancer really increased if patients with ulcerative colitis have primary sclerosing cholangitis?
Jung Wook Lee, Won Moon
Intest Res. 2023;21(2):171-173.   Published online April 28, 2023
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Close layer
prev next
Prevention of postoperative recurrence in Crohn’s disease: the never-ending story
Jung-Bin Park, Sang Hyoung Park
Intest Res. 2022;20(3):279-280.   Published online July 26, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?
Yong Eun Park
Intest Res. 2022;20(2):157-158.   Published online April 29, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?
Jihye Park
Intest Res. 2022;20(1):1-2.   Published online January 26, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Does cytomegalovirus load predict the outcome of acute severe ulcerative colitis?
You Sun Kim
Intest Res. 2021;19(4):357-359.   Published online October 26, 2021
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Inflammatory bowel diseases
The first step to unveil the epidemiology of inflammatory bowel disease in Central Asia
Seung Wook Hong, Byong Duk Ye
Intest Res. 2020;18(4):345-346.   Published online October 26, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Education levels and survival in colorectal cancer: is there really an obvious association?
Bruna Valiati, Rodrigo Oliva Perez, Paulo Gustavo Kotze
Intest Res. 2020;18(3):247-248.   Published online July 20, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Inflammatory bowel diseases
Tumor necrosis factor-α inhibitor use in patients with malignancy: is it safe?
Gyu Man Oh, Won Moon
Intest Res. 2020;18(3):245-246.   Published online July 20, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Complementary and alternative medicine in patients with inflammatory bowel disease: hype or evidence?
Jae Myung Cha
Intest Res. 2020;18(2):141-143.   Published online April 20, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Enteral nutrition in the biologic era: learn from yesterday, live for today, hope for tomorrow
Tadakazu Hisamatsu
Intest Res. 2020;18(2):139-140.   Published online April 20, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
IBD
Tacrolimus in pediatric ulcerative colitis: does it have a role?
Seung Kim
Intest Res. 2019;17(4):441-442.   Published online October 28, 2019
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Close layer
prev next
Close layer
prev next
Close layer
prev next
  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD

ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2023 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next